Health
Research team identifies potential drug to treat SARS-CoV-2 – Medical Xpress
A federally approved heart medication shows significant effectiveness in interfering with SARS-CoV-2 entry into the human cell host, according to a new study by…
A federally approved heart medication shows significant effectiveness in interfering with SARS-CoV-2 entry into the human cell host, according to a new study by a research team from Texas A&M University and The University of Texas Medical Branch (UTMB).
The medication bepridil, which goes by the trade name Vascor, is currently approved by the U.S. Food and Drug Administration (FDA) to treat angina, a heart condition.
The team’s leaders are College of Science professor Wenshe Ray Liu, professor and…
-
Noosa News13 hours agoWilliam Robinson dies aged 89
-
Business17 hours agoMacquarie tips 14% upside for this ASX tech stock
-
Business18 hours agoWhat to do with these 3 ASX 200 retail shares after strong price runs: experts
-
General13 hours agoCalls for corruption probe into completion of mayor’s Surfers Paradise Bowls Club site purchase